Your browser doesn't support javascript.
loading
Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?
Ferrara, Francesco; Porta, Raffaele La; Santilli, Priscilla; D'Aiuto, Vilma; Vitiello, Antonio.
Affiliation
  • Ferrara F; Department of Pharmaceutical, Usl Umbria 1, Perugia, Italy.
  • Porta R; Department of Clinical Pathology, Asur Marche, Macerata, Italy.
  • Santilli P; Department of Pharmaceutical, Usl Umbria 1, Perugia, Italy.
  • D'Aiuto V; Department of Pharmaceutical, Usl Umbria 1, Perugia, Italy.
  • Vitiello A; Department of Pharmaceutical, Usl Umbria 1, Perugia, Italy.
Indian J Pharmacol ; 52(5): 441-442, 2020.
Article in En | MEDLINE | ID: mdl-33283779
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pandemics / COVID-19 / Immunosuppressive Agents / Multiple Sclerosis Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Indian J Pharmacol Year: 2020 Document type: Article Affiliation country: Italy
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pandemics / COVID-19 / Immunosuppressive Agents / Multiple Sclerosis Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Indian J Pharmacol Year: 2020 Document type: Article Affiliation country: Italy